| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |